Altamira Therapeutics Ltd.: xbrl:AdjustedWeightedAverageShares
| Value | {"unit": "shares", "value": 812167} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/fe9357ca-2d88-4695-a5f0-7a9d872ed74e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-20-009292Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/fe9357ca-2d88-4695-a5f0-7a9d872ed74e
History
- no predecessors — first report